ACCD — Accolade Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Accolade, fiscal year end - February 29th, USD millions except per share, conversion factor applied.

	2020 February 29th	2021 February 28th	2022 February 28th	2023 February 28th	2024 February 29th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33.2	434	366	321	237
Net Total Accounts Receivable
Net Total Receivables	1.19	11.8	30.8	26.7	27.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	48.9	454	409	366	285
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	13.6	9.23	44.9	44.3	47.5
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	73.2	476	1,286	903	788
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	70	79.1	112	119	108
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	97	84.7	430	429	343
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-23.8	391	856	474	445
Total Liabilities & Shareholders' Equity	73.2	476	1,286	903	788
Total Common Shares Outstanding